Home/Filings/4/0001562180-18-002839
4//SEC Filing

Beddingfield III Frederick 4

Accession 0001562180-18-002839

CIK 0001656328other

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 9:21 PM ET

Size

7.6 KB

Accession

0001562180-18-002839

Insider Transaction Report

Form 4
Period: 2018-06-01
Beddingfield III Frederick
DirectorPresident & CEO
Transactions
  • Award

    Stock Options (Right to buy)

    2018-06-01+190,910190,910 total
    Exercise: $15.08Exp: 2028-06-01Common Stock (190,910 underlying)
Holdings
  • Common Stock

    (indirect: See Footnote)
    112,614
  • Common Stock

    603,208
Footnotes (3)
  • [F1]Includes 1,962 shares of the Issuer's common stock acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 31, 2018.
  • [F2]The shares are directly held by the Beddingfield Family Trust.
  • [F3]Twenty-Five percent (25%) of the shares subject to the option vest and become exercisable on the first anniversary measured from June 1, 2018, and the remaining shares subject to the option vest and become exercisable in 36 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Issuer

Sienna Biopharmaceuticals, Inc.

CIK 0001656328

Entity typeother

Related Parties

1
  • filerCIK 0001573074

Filing Metadata

Form type
4
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 9:21 PM ET
Size
7.6 KB